↓ Skip to main content

Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, April 2015
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
43 Mendeley